Courtney V. Fletcher
Affiliations: | 1983-2002 | Experimental and Clinical Pharmacology | University of Minnesota, Twin Cities, Minneapolis, MN |
| 2002-2007 | Clinical Pharmacy | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO | |
| 2007- | Pharmacy | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
antiviral agentsWebsite:
https://www.unmc.edu/aboutus/leadership/dean-directors/cop-dean.htmlGoogle:
"Courtney V. Fletcher"Bio:
http://www.washington.edu/provost/files/2014/04/Fletcher_Courtney_cv.pdf
Mean distance: (not calculated yet)
Children
Sign in to add trainee| Gautam Baheti | grad student | 2012 | University of Nebraska Medical Center |
| Edward P. Acosta | post-doc | 1992-1994 | UMN |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Harwood OE, Matschke LM, Moriarty RV, et al. (2023) CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection. Plos Pathogens. 19: e1011676 |
| Harwood OE, Matschke LM, Moriarty RV, et al. (2023) CD8+ cells and small viral reservoirs facilitate post-ART control of SIV in Mauritian cynomolgus macaques. Biorxiv : the Preprint Server For Biology |
| Fletcher CV, Kroon E, Schacker T, et al. (2022) Persistent HIV transcription and Variable ARV penetration in lymph nodes during plasma viral suppression. Aids (London, England) |
| Miller JS, Davis ZB, Helgeson E, et al. (2022) Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial. Nature Medicine |
| Podany AT, Pham M, Sizemore E, et al. (2021) Efavirenz pharmacokinetics and HIV-1 viral suppression among patients receiving TB treatment containing daily high-dose rifapentine. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Kendall MA, Lalloo U, Fletcher CV, et al. (2021) Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 73: 706-715 |
| Dyavar SR, Kumar S, Gautam N, et al. (2021) Intramuscular and subcutaneous administration of antiretroviral drugs, compared with oral, enhances delivery to lymphoid tissues in BALB/c mice. The Journal of Antimicrobial Chemotherapy |
| Hoque TMD, Cattin A, Whyte-Allman SK, et al. (2021) Antiretroviral Drug Transporters and Metabolic Enzymes in Circulating Monocytes and Monocyte-Derived Macrophages of ART-Treated People Living With HIV and HIV-Uninfected Individuals. Journal of Acquired Immune Deficiency Syndromes (1999). 87: 1093-1101 |
| Fletcher CV, Dyavar SR, Acharya A, et al. (2021) The Contributions of Clinical Pharmacology to HIV Cure Research. Clinical Pharmacology and Therapeutics |
| Kendall MA, Lalloo U, Fletcher CV, et al. (2021) Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin vs. Lopinavir/Ritonavir + Daily Rifabutin for Treatment of HIV-TB Coinfection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |